J. Vincent, J. Rello, J. Marshall, E. Silva, A. Anzueto et al., International Study of the Prevalence and Outcomes of Infection in Intensive Care Units, JAMA, vol.302, issue.21, pp.2323-2329, 2009.
DOI : 10.1001/jama.2009.1754

M. Morrell, V. Fraser, and M. Kollef, Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, pp.3640-3645, 2005.
DOI : 10.1128/AAC.49.9.3640-3645.2005

M. Parkins, D. Sabuda, S. Elsayed, and K. Laupland, Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections, Journal of Antimicrobial Chemotherapy, vol.60, issue.3, pp.613-618, 2007.
DOI : 10.1093/jac/dkm212

K. Garey, M. Rege, M. Pai, D. Mingo, K. Suda et al., Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi???Institutional Study, Clinical Infectious Diseases, vol.43, issue.1, pp.25-31, 2006.
DOI : 10.1086/504810

O. Leroy, J. Gangneux, P. Montravers, J. Mira, F. Gouin et al., AmarCand Study Group: Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France Crit Care Med, pp.1612-1618, 2005.

O. Leroy, J. Mira, P. Montravers, J. Gangneux, F. Gouin et al., Candidoses invasives en r??animation??: analyse des traitements antifongiques au cours de l???enqu??te fran??aise AmarCand, Annales Fran??aises d'Anesth??sie et de R??animation, vol.27, issue.12, pp.999-1007, 2008.
DOI : 10.1016/j.annfar.2008.10.004

S. Ascioglu, J. Rex, B. De-pauw, J. Bennett, J. Bille et al., Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus, Clinical Infectious Diseases, vol.34, issue.1, pp.7-14, 2002.
DOI : 10.1086/323335

M. Cheng, Y. Yang, T. Yao, C. Lin, J. Liu et al., Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species, BMC Infectious Diseases, vol.48, issue.Suppl 2, p.22, 2005.
DOI : 10.1016/j.diagmicrobio.2003.09.008

A. Shorr, D. Lazarus, J. Sherner, W. Jackson, M. Morrel et al., Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia, Critical Care Medicine, vol.35, issue.4, pp.1077-1083, 2007.
DOI : 10.1097/01.CCM.0000259379.97694.00

D. Horn, D. Neofytos, E. Anaissie, J. Fishman, W. Steinbach et al., Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry, Clinical Infectious Diseases, vol.48, issue.12, pp.1695-1703, 2009.
DOI : 10.1086/599039

E. Playford, D. Marriott, Q. Nguyen, S. Chen, D. Ellis et al., Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp., Critical Care Medicine, vol.36, issue.7, pp.2034-2039, 2008.
DOI : 10.1097/CCM.0b013e3181760f42

J. Chow, Y. Golan, R. Ruthazer, A. Karchmer, Y. Carmeli et al., in the Intensive Care Unit, Clinical Infectious Diseases, vol.46, issue.8, pp.1206-1213, 2008.
DOI : 10.1086/529435

A. Holley, J. Dulhunty, S. Blot, . J. Lipman, S. Lobo et al., Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units, International Journal of Antimicrobial Agents, vol.33, issue.6, p.554, 2009.
DOI : 10.1016/j.ijantimicag.2008.10.035

. Société-française-d, Anesthésie et de Réanimation Société de Pathologie Infectieuse de Langue Française Société de Réanimation de Langue Française Société Française d'Hématologie Société Française de Mycologie Médicale Société Française de Greffe de Moelle (Consensus Conference): Management of invasive candidiasis and aspergillosis in adults, Rev Pneumol Clin, vol.60, pp.289-293, 2004.

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, . Jr et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-535, 2009.
DOI : 10.1086/596757

W. Mccabe and G. Jackson, Gram-Negative Bacteremia, Archives of Internal Medicine, vol.110, issue.6, pp.847-855, 1962.
DOI : 10.1001/archinte.1962.03620240029006

. Leroy, 1186/cc9033 Cite this article as Comparison of albicans vs. non-albicans candidemia in French intensive care units Critical Care, pp.10-98, 2010.